May 14, 2020
Agenus NextGen CTLA-4 Antibody (AGEN1181) Data to be Presented at ASCO
May 12, 2020
YUMAB Identifies Promising Candidate for COVID-19 Antibody Therapy
May 11, 2020
Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration
May 07, 2020
Agenus First Quarter Results and Update
May 05, 2020
Global Nucleic Acid Isolation and Purification Industry, 2020-2029 - Detailed Company Profiles of 22 Key Players, Interviews with KOLs of 20 Leading & Emerging Companies
Apr 30, 2020
Sensiva Health Files Patent Application for Most Comprehensive Risk Stratification for Contagious Disease Method Yet
Apr 30, 2020
WuXi Biologics and Aravive Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer and Fibrosis Using the WuXiBody(TM) Platform
Apr 24, 2020
ThermoGenesis and ImmuneCyte Joint Venture Developing Several Convalescent Plasma and Antibody Therapeutic Approaches Against COVID-19, Featured on FOX40 and Other Local News Outlets
Apr 16, 2020
Alphamab Oncology Received U.S. FDA IND Approval to Initiate A Phase II Clinical Trial of KN046 For NSCLC in the United States
Apr 14, 2020
Macromoltek Deploys Computational Design Platform To Enable Cytovia Therapeutics Drug Development For COVID-19
Apr 07, 2020
GenScript ProBio and Eutilex Enter into Exclusive Strategic Collaboration on Plasmid and Virus Process Development and Manufacturing for CAR-T Programs
Apr 02, 2020
Bolt Biotherapeutics Appoints Nathan Ihle, Ph.D., as Vice President of CMC and Quality
Apr 01, 2020
Macromoltek Announces Computational De Novo Antibody Design Offering, Targeting COVID-19
Mar 31, 2020
Phio Announces Positive New Data Validating the INTASYL(TM) Immunotherapy Platform's Ability to Develop Novel Compounds Capable of Inhibiting Cancer Tumor Growth
Mar 30, 2020
Global Antibody Contract Manufacturing Market (2020 to 2030)
Mar 27, 2020
GenScript ProBio Congratulates XlifeSciences on the Start of TAEST16001 Early Phase Clinical Trial
Mar 25, 2020
Berkeley Lights Announces the Global Emerging Pathogen Antibody Discovery Consortium (GEPAD) to Attack COVID-19 and Other Viruses
Mar 24, 2020
Apexigen Completes $123 Million Series C Financing To Advance Clinical Pipeline
Mar 18, 2020
Avantor® Launches New Protein A Chromatography Resin - PROchievA - that Provides Supply Chain Flexibility and Improves Downstream Purification Performance for Monoclonal Antibodies (mAbs) Production
Mar 12, 2020
ImmunoPrecise Announces the Launch of PolyTope mAb Therapy(TM) to Tackle Coronavirus Pandemic